cmi_logo.png
[Latest] Global Lung Tumor Market Size/Share Worth USD 46.3 Billion by 2033 at a 7.7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
April 15, 2024 12:30 ET | Custom Market Insights
Austin, TX, USA, April 15, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Lung Tumor Market Size, Trends and Insights By Product (Imaging systems, Biopsy...
U.S. In-Vitro Diagnostics Market
United States In-Vitro Diagnostics Insights Report 2024: Market to Reach $44.95 Billion by 2029 with Abbott, Diasorin, Biomerieux, Danaher, Bio-Rad, and Siemens Healthinees Dominating
April 10, 2024 10:12 ET | Research and Markets
Dublin, April 10, 2024 (GLOBE NEWSWIRE) -- The "U.S. In-Vitro Diagnostics Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering.The U.S. In-Vitro...
cmi_logo.png
[Latest] Global Hereditary Cancer Testing Market Size/Share Worth USD 12.1 Billion by 2033 at a 7.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
April 02, 2024 14:00 ET | Custom Market Insights
Austin, TX, USA, April 02, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Hereditary Cancer Testing Market Size, Trends and Insights By Disease Type...
22157.jpg
Biopsy Devices Market Reveals Key Insights and Market Trends Through 2033
March 25, 2024 11:12 ET | Research and Markets
Dublin, March 25, 2024 (GLOBE NEWSWIRE) -- The "Biopsy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033" report has been added to ...
Global Liquid Biopsy Market
Global Liquid Biopsy Research Report 2024-2030 - POCT Revolutionizes Liquid Biopsy, Providing Rapid and Accurate Diagnostics at Bedside
February 19, 2024 04:03 ET | Research and Markets
Dublin, Feb. 19, 2024 (GLOBE NEWSWIRE) -- The "Global Liquid Biopsy Market, Size, Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has been...
Asia-Pacific EV-Based Liquid Biopsy Market
Asia-Pacific EV-Based Liquid Biopsy Market Report 2024: Analysis and Forecasts 2023-2032 - Increasing Emphasis on Personalized Medical Approaches Fueling Growth
February 06, 2024 09:22 ET | Research and Markets
Dublin, Feb. 06, 2024 (GLOBE NEWSWIRE) -- The "Asia-Pacific EV-Based Liquid Biopsy Market: Analysis and Forecast, 2023-2032" report has been added to ResearchAndMarkets.com's offering.The...
22157.jpg
Antibody Immunohistochemistry Market Analysis and Forecast to 2028, Featuring Profiles of Merck, Bio-Techne, BD Biosciences, Thermo Fisher Scientific, Amoy Diagnostics, Sino Biological, and ACRO Biosystems
January 31, 2024 06:16 ET | Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Antibody Immunohistochemistry Market: Trends, Opportunities and Competitive Analysis 2023-2028" report has been added to ResearchAndMarkets.com's...
European EV-based Liquid Biopsy Market
Europe EV-based Liquid Biopsy Market Report 2023-2032: Regional Revenue Breakdowns and Assessment of the Competitive Landscape
January 29, 2024 13:06 ET | Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Europe EV-Based Liquid Biopsy Market - Analysis and Forecast, 2023-2032" report has been added to ResearchAndMarkets.com's offering.The Europe...
22157.jpg
Global Biopsy Devices Market Analysis to 2033: Segments, Shares, Regulatory Landscape, Reimbursement Policies, Procedures, Companies
January 23, 2024 16:48 ET | Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Biopsy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033" report has been added to ...
Sagimet-Logo-for-light-bg-FIN.png
Sagimet Biosciences Announces Positive Topline Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 NASH
January 22, 2024 07:00 ET | Sagimet Biosciences Inc.
Denifanstat achieved statistically significant results on primary and multiple secondary endpoints in a 52-week clinical trial of 168 NASH patients with stage 2 or 3 fibrosis Primary efficacy...